Hilary Hochberg
Advanced Radiology Clerkship
Dr. Gillian Lieberman
Down’s Syndrome:
Ultrasound Screening
2
Gillian Lieberman, MD
Patient M.C.
•
32 year old female presents at 16 weeks
gestational age with “
abnormal triple screen test
”
•
Obstetrician referred M.C. for ultrasound
evaluation to look for signs of Down’s syndrome
or other congenital anomalies.
3
Screening for Down syndrome by maternal serum
markers:
THE TRIPLE SCREEN
AFP
HcG
UE3
Absolute
58 ng/ml
97.36 ju/ml
28 ng/ml
Relative
1.93 MoM
3.12 MoM
0.42 MoM
Pt M.C.
4
Gillian Lieberman, MD
http://www.fetalmedicine.com/11-14scanbook/Figures/fig01-04.htm
Maternal age-related risk for
chromosomal abnormalities
5
Prevalence of trisomy 21 by maternal age and
gestational age
Snijders RJM, Sundberg K, Holzgreve W, Henry G, Nicolaides KH. Maternal age and gestation- specific risk for trisomy 21. Ultrasound Obstet Gynecol 1999;13:167–70
6
Gillian Lieberman, MD
Ultrasound Screening of
Down’s Syndrome
•
Trisomy 21: Most common chromosomal abnormality
Average incidence 1:800 live births
•
Current second-trimester ultrasound screening detects
up to 60% of Down’s syndrome fetuses
*•
Helpful to correlate a large number of relatively
nonspecific visual and biometric markers
•
Ideally, perform at age when confirmatory diagnosis can be made, safe
termination can be offered
Image:http://anatomy.med.unsw.edu.au /cbl/embryo/sysnote.htm
7
Trisomy
21 Trisomy 18 Trisomy 13 Triploidy Turner
Skull/brain Strawberry-shaped head Brachycephaly Microcephaly Ventriculomegaly Holoprosencephaly Choroid plexus cysts Absent corpus callosum Posterior fossa cyst Enlarged cisterna magna
– + – + – + – + + + + – + – + + + + – + + – + – – + + – – – + – – – – – – + + – – – – – – Face/neck Facial cleft Micrognathia Nuchal edema Cystic hygromata – – + – + + + – + – + – – + – – – – – + Chest Diaphragmatic hernia Cardiac abnormality – + + + + + – + – + Abdomen Exomphalos Duodenal atresia Collapsed stomach Mild hydronephrosis Other renal abnormalities – + + + + + – + + + + – – + + – – – – + – – – + – Other Hydrops
Small for gestational age Relatively short femur Clinodactyly Overlapping fingers Polydactyly Syndactyly Talipes + – + + – – – – – + + – + – – + – – – – – + – + – + + – – – + + + + + – – – – –
Sonographic
finding
8
Gillian Lieberman, MD
http://www.fetalmedicine.com/nuchal.htm
Unclear physiological basis of fluid accumulation
1. Increased risk of associated cardiac abnormalities
2. Increased hyaluronanidase in ECM
Nuchal translucency >
3mm abnormal
NUCHAL TRANSLUCENCY:
1
st
Trimester
9
In one large series of 1015 patients, nuchal translucency thickness
of 3mm, 4mm, 5mm, and > 6mm increased risk of trisomy 3x,
18x, 28x and 36x higher than respective risk expected based upon
maternal age alone.
Pandya PP, Kondylios A, Hilbert L, Snijders RJ, Nicolaides KH. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 1995 Jan;5(1):15-9.
*
*
10
Gillian Lieberman, MD
Nuchal Fold: 2
nd
Trimester
•
Thickened nuchal skin
foldÆOuter skull table to
outer skin surface
•
>6 mm abnormal at 19-24
weeks
(83% specificity)*
•
40% Down’s fetuses have
thickened fold
Benacerraf BR, Gelman R, Frigoletto FD: Sonographic identification of second-trimester fetuses with Down’s syndrome. NEJM 317:1371, 1987.
*
*
11
Choroid Plexus Cysts
•
Present in 2% of normal pregnancies
•
Folding of neuroepithelium
Æ
accumulate CSF
•
Most resolve by weeks 26-28.
http://www.thefetus.net/sections/articles/Technique/chapter-10/aneuploidies.html
Must be imaged in 2
orthogonal planes and
> 3 mm.
12 Gillian Lieberman, MD
Echogenic Bowel
http://www.thefetus.net/sections/articles/Technique/chapter-10/aneuploidies.html•
0.5% normal fetuses
•
Usually no significance
•
Cause unknown
Hypoperistalsis
Meconium fluid content
Gut ischemia
Also found in cases of:
•
fetal viral infection, ex: CMV
•
small bowel atresia/volvulus
•
growth retardation
•
cystic fibrosis
13
http://brighamrad.harvard.edu/Cases/bwh/images/35/Laing12US.GIF
Duodenal Atresia
Double-bubble sign
•
1/10,000 births
•
5-8% Down’s Syndrome fetuses
•
30% of fetuses with duodenal
14 Gillian Lieberman, MD
Echogenic
Intracardiac
Focus
Image 1 Image 2•
Single foci quadruples risk of Down’s syndrome
•
3-8 % normal 2nd trimester ultrasounds
15
Image1:http://www.thefetus.net/sections/articles/Technique/chapter-10/aneuploidies.html
Image2: Winter, Thomas C, MD et al. Echogenic Intracardiac Focus in 2nd-Trimester Fetuses with Trisomy 21: Usefulness
as a US Marker. Radiology 2000; 216; 450-456.
16
Gillian Lieberman, MD
Atrioventricular Septal Defect
•
AKA endocardial cushion defect; 7% CHD; 1/3000 births
•
Endocardial cushions form the lower atrial septum, the upper
ventricular septum, the septal leaflet of the tricuspid
valve and the anterior leaflet of the mitral valve. An
ECD defect is due to abnormal development of these
endocardial cushions.
•
ASD+VSD
Î
a common opening to all chambers of heart
•
>50% of DS fetuses have CHD (44% have AVSD)
43% of fetuses with AVSD have DS*
*Paladini D, Tartaglione A, Agangi A, Teodoro A, Forleo F, Borghese A, Martinelli P. The association between congenital heart disease and Down syndrome in prenatal life. Ultrasound Obstet Gynecol 2000 Feb;15(2):104-8
17
http://www.tmc.edu/thi/canal.html
http://www.acuson.com/cme/pdf/quiz30.pdf
18
Gillian Lieberman, MD
Images: http://www.thefetus.net/sections/articles/Technique/chapter-10/aneuploidies.html
Short femur
Mild renal pelvic dilatation
(
>4 mm at <33 wks abnormal)
Sandal gap
Other sonographic
features
Snijders RJM, Platt LD, Greene N, Carlson D, Krakow D, Gregory K, Bradley K. Femur length and trisomy 21: impact of gestational age on screening efficiency.
19
Dilated Pelvis
20
Gillian Lieberman, MD
Ultrasound screening
for Down’s syndrome
Useful information
Confusion
Many trisomy 21 findings overlap with
normal fetus findings
21
Sonographic Index for DS:
2
nd
trimester fetus
Findings
Major anomaly
Nuchal Fold >6mm
Short Femur
Short Humerus
Pyelectasis >4mm
Hyperechoic Bowel
Echogenic Focus
Score
2
2
1
1
1
1
1
Callen, PW. Ultrasononography in Obstetrics and Gynecology. 4th edn. WB Saunders CO. Philadelphia 2000.
Score > 2
82% DS (4%
false positive)
22
Gillian Lieberman, MD
Patient M.C.
Ultrasound: normal. Obstetrician offered
amniocentesis because calculated risk of fetus
with trisomy 21 > risk of amnio complications.
Patient expressed that she would not abort fetus
regardless of amnio results; however, she and
her husband wanted psychological preparation
and requested karyotype analysis.
23
References
Bradley K. Femur length and trisomy 21: impact of gestational age on screening efficiency.
Ultrasound Obstet Gynecol 2000; 16:142-145.
Callen, PW. Ultrasononography in Obstetrics and Gynecology. 4th edn. WB Saunders CO. Philadelphia 2000.
Devore, GR. Trisomy 21: 91% detection rate using second-trimester ultrasound markers.
Ultrasound Obstet Gynecol 2000; 16:133-141.
Filly RA. Obstetrical sonography: the best way to terrify a pregnant woman. J Ultrasound Med
2000; 19: 1-5.
Graupe M, Naylor C, Greene N, Carlson D, Platt L. Trisomy 21: Second-Trimester Ultrasound.
Clinics in Perinatology 28 (2): 303-319.
Paladini D, Tartaglione A, Agangi A, Teodoro A, Forleo F, Borghese A, Martinelli P. The association between congenital heart disease and Down syndrome in prenatal life. Ultrasound Obstet Gynecol 2000 Feb;15(2):104-8
Pilu G, Nicolaides KH. Diagnosis of fetal abnormalities. The 18-23 week scan. The Parthenon Publishing Group: New York, 1999.
Simpson J. Cardiac echogenic focus. 1999 Prenat Diagn 19:972-975.
Smith-Bindman R, Hosmer W, Feldstein VA, Deeks JJ, Goldberg JD. Second-trimester ultrasound to detect fetuses with Down syndrome: A meta-analysis. JAMA 285 (8): 1044-1055.
Snijders RJM, Platt LD, Greene N, Carlson D, Krakow D, Gregory K, Sepkulveda W, Sebire NJ. Fetal echogenic bowel: a complex scenario. Ultrasound Obstet Gynecol 2000; 16: 510-514.
Pandya PP, Kondylios A, Hilbert L, Snijders RJ, Nicolaides KH. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 1995 Jan;5(1):15-9.
Twining P, McHugo J, Pilling D. Textbook of Fetal Abnormalities. Churchill Livingstone: London, 1999.
24
Gillian Lieberman, MD
Acknowledgments
•
Dr. Gillian Lieberman
•
Pamela Lepkowski